Successful application of anticancer therapy, and especially photodynamic therapy (PDT) mediated by type I1 (PDTII) processes, depends on the oxygen content within the tumor before, during and after treatment. The high consumption of oxygen during type I1 PDT imposes constraints on therapy strategies. Although rates of oxygen consumption and repletion during PDTII were suggested by theoretical studies, direct measurements have not been reported. Application of a novel oxygen sensor allowed continuous and direct in sifu measurements (up to a depth of 8-9 mm from the tumor surface and for several hours) of temporal variations in the oxygen partial pressure (pOz) during PDT. Highly pigmented M2R mouse melanoma tumors implanted in CD1 nude mice were treated with bacteriochlorophyll+erine (Bchl-Ser; a new photodynamic reagent) and were subjected to fractionated illumination (700 < A < 900 nm) at a fluence rate of 12 mW cm+. This illumination led to total oxygen depletion with an average consumption rate of 7.2 pM(Oz) s-l. Spontaneous reoxygenation (at an average rate of 2.5 pM(O,)/s) was observed during the following dark period. These rates are in good agreement with theoretical considerations (Foster et al., Radiat. Res. 126, 296,1991 and Henning et al., Radiut. Res. 142,221,1995). The observed patterns of oxygen consumption and recovery during prolonged periods of Iightldark cycles were interpreted in terms of vasculature damage and sensitizer clearance. The presented data support the previously suggested advantages of fractionated illumination for type I1 photodynamic processes.
INTRODUCTION
In type I1 photodynamic therapy (PDTII)? (1,2), a photosensitizing drug, light and oxygen are used to cause photochemically induced cell death. Singlet oxygen molecules ( lo2) are generated via energy transfer from sensitizing dye molecules that are administered to the tumor and then excited by either visible (VIS) or near infrared (NIR) radiation (2,3). Tumor destruction during PDTII is believed to be achieved by in situ generation of lo2 and the consequent oxidation of cellular constituents (4-6). However, the O2 distribution in tumor tissues is often heterogeneous (7.8). Cells in hypoxic tumor regions are thought to be more resistant to PDTII, as well as to radio-and chemotherapies (1,4,9). Furthermore, extensive photodynamic activity near the blood capillaries causes a temporary reduction of the oxygen concentration at remote tumor zones, which further limits the tumor response to PDTII (10,ll). Thus, information on the temporal and spatial oxygen levels in tumors is important for selecting the therapy strategy and predicting its efficiency.
Theoretical studies have related the rate of oxygen depletion with a particular light dose, spectral characteristics and concentration of the applied photosensitizer. Almost linear relationships were predicted between the initial concentration and depletion time of oxygen in the tumor tissue (10) (Figs. 1 and 2) . Following these studies, it should take -12 s to reduce the oxygen concentration in a tumor tissue to 100 pA4 by providing light at 50 mW cm-2 to hematoporphyrin derivative (HPD; 5-10 p,g/g treated tissue). Completion of tumor reoxygenation (at a rate of 1-4 p W s ) is expected to take 30-60 s (11). According to these studies, shorter dark periods (approaching continuous illumination), higher fluence rates and/or longer illumination times would reduce the efficiency of PDTII. especially in zones that are fairly remote from the tumor vascular bed. Significantly higher rates of animal survival after PDT with fractionated ?Abbreviations: Bchl-Ser, bacteriochlorophyll-serine; HPD, hematoporphyrin derivative; NIR, near infrared; '0,. singlet oxygen; PDT, photodynamic therapy; PDTII, type I1 PDT; PO,, oxygen partial pressure; VIS, visible. In vivo measurement of p 0 2 and the dynamic response of the oxygen microsensor. The PO, in striated muscle (Psoas) (A) and subcutaneous tissue (B) is depicted. In panel A, the mouse was ventilated at t = 6:40 and 34:40 with 100% O2 for 2 min by using a ventilation mask. In panel B, spontaneous increase in tissue PO,, concomitant with movements of the anesthetized animal, was noticed at t = 36:OO min. Therefore, the mouse was reanesthetized at t = 39:OO min. In panel B (continued), the mouse was ventilated with 4% oxygen for 1 min at t = 55:OO min. and with 100% oxygen for 1.5 and 2 min at t = 104:00 and 11O:OO min, respectively. At t = 117 min. the experiment was terminated and the sensor tip pulled out of the tumor and allowed to equilibrate with air. Panels B and B (continued) depict data obtained from the same mouse.
rather than continuous illumination (of similar total energy) experimentally supported these claims (10-12). Quantitation of the tumor oxygen content during the course of PDT was attempted in several studies (13) (14) (15) . Application of an indirect method (utilizing the transcutaneous Clark electrode) for follow-up of tumor oxygen levels enabled the calculation of oxygen consumption rates of -10-2-10-3 p M 02/s in Photofrin 11-based PDT (15). This value is two to three orders of magnitude less than predicted (10,ll). The precision and time resolution of this indirect and similar techniques for monitoring the kinetics of oxygen consumption during PDT were low due to the inherent limitations of polarographic assays. For example, oxygen consumption by the electrode and the electrical current involved in polarographic techniques result in low accuracy of measurements, especially at low oxygen tensions where the signal-to-noise ratio is low. Furthermore, the stability of the electrode could be affected by contamination (protein poisoning) (14) . The use of transcutaneous electrodes requires heating of the skin surface to 44°C in order to accelerate oxygen diffusion, which imposes an undesirable impact of the probe itself. The dimensions of these electrodes limit their spatial resolution. Cumulatively, these shortcomings confine the application of polarographic assays to subcutaneous tumors (15). Other methods for measuring tissue oxygen and related parameters consist of more complex procedures that usually involve analyses of tissue biopsies (14).
The drawbacks of existing methodologies for in vivo determination of oxygen concentrations in tumors during PDTII prompted the search for in situ measurements. An optical sensor, developed by us to monitor oxygen partial pressure (PO,) in blood (16,17) seemed suitable for performing similar measurements in solid tissues. When inserted into blood or tissue, this optical-sensing fiber continuously probes PO, by measuring the fluorescence of pyrene immobilized on a solid support, which is quenched in the presence of 02. This probe can be used to monitor even low local concentrations of oxygen (1 mmHg). Temporal changes in p 0 2 are immediately sensed with a high time resolution (seconds). Furthermore, this sensor does not consume oxygen and is protected from poisoning (16, 17) .
Herein, this novel sensor was utilized to monitor the oxygen levels in implanted M2R mouse melanoma tumors during PDT. Such fully pigmented tumors cannot be treated by Photofrin I1 and other VIS-red-absorbing sensitizers because the red light beam utilized with these sensitizers is absorbed and scattered to a great extent by the melanin-a phenomenon that limits the depth of Photofrin sensitization to 1-3 mm. In order to enable treatment at deeper locations, a new photosensitizer, bacteriochlorophyll-serine (Bchl-Ser), was synthesized (18) (19) (20) (21) . This photosensitizer is a water-soluble molecule that strongly absorbs in the NIR (extinction coefficient of 105 Mlcm at hmax = 770-780 nm) and delivers high photocytotoxicity (-200 times that of Photosan, a hematoporphyrin-based drug) in cell cultures (21). Bacteriochlorophyll-serine exhibits low dark toxicity, fast clearance rates from healthy animal tissues and slower clearance rates from tumor tissues (half-life times of 2 and 15 h, respectively) (21). These properties enable delivery of photodynamic activity throughout the entire volume of large solid tumors. The therapeutic ability of Bchl-Ser in PDT was tested and found to be efficient ia the animal tumor model described below (21-24) with 34 of 40 animals completely cured to date (Zilberstein et al., in preparation).
Photosensitizer
Bacteriochlorophyll-serine was prepared from the natural pigment, bacteriochlorophyll-a, that was chemically modified at the C-17 propionic residue of its macrocycle and conjugated to a serine molecule (18-21). The Bchl-Ser was kept dry under argon in the dark at -20°C until used.
Tumor model
The M2R mouse melanoma cells were maintained as monolayers, as previously described (25). For tumor implantation, the cells were scraped off the plates, suspended in normal saline and subcutaneously injected ( I X 106 cells/25 pL) into the backs of CDl male (30-35 g) nude mice, as previously described (21.26). By -4-5 weeks, the melanotic tumors appeared as dark, solid and confined structures with an average weight of 4-6 g.
Anesthesia
Mice were anesthetized by intraperitoneal injections (40 pL) of ketamine (5 mg/kg; Rhone Merieux, Lyon, France) and xylazine (1 mg/kg; Bayer, Leverkusen, Germany). This cocktail has a minimal effect on blood flow and, consequently. little effect on the oxygen levels within the treated tissue. The applied dose was sufficient to keep the mice anesthetized for -30-40 min. Additional injections (10-20 pL) were performed as needed to maintain anesthesia until the conclusion of the treatment (up to 8 h).
Administration of drug
The Bchl-Ser (200 pg/50 pL of alcohol [95%]/saline [1:1]) was administered to anesthetized mice by direct injection into the tumor using a 28 X 112 gauge needle. In oxygen measurements, the drug was injected close to the site of the microsensor.
Light irradiation (a) In light-dependent oxygen depletion experiments, a home-built light source (equipped with a 100 W white halogen lamp, RG-700 cut-off filter and 10 cm water layer filter) provided radiation at 700 < A < 900 nm with an average power of 12 mW cm-2 and was fractionated as described in the individual experiments. The irradiating light was controlled by an optical lens and the illuminated spot on the tissue (diameter 1.2 cm) covered the examined area of the tumor. Detrimental effects due to heating (edema and/or skin injury) were not observed at the site of illumination. (b) In PDT experiments, the same light source and settings were used, except that the RG filter was removed, the average power was 100 mW c m 2 , the light was emitted continuously for 30 min and the light spot covered the entire tumor. 
*n = Number of animals.
?Measurements were conducted in five mice: Psoas two and Recrus abdominis three.
Histopathology
Mice were sacrificed by cervical dislocation at appropriate stages of the photodynamic treatment, and the tumor was removed and placed in Buene's fixative. Following a fixation of 24 h, the tumor was paraffin-embedded, sectioned (10 pm) and the sections stained with hematoxylideosin with light green as previously described (26). Pathological differences between samples were assessed by light microscopy (Optiphot-2, Nikon, Japan).
Oxygen measurements
Oxygen microsensor. The Blood Gas Monitor (developed by OST, Kiryat Bialik, Israel) is an on-line, real-time system that provides continuous monitoring of blood oxygen with a time response that is diffusion limited. This oxygen sensor monitors the fluorescence of a pyrene derivative. which is quenched in a concentration-dependent manner by molecular oxygen. The pyrene molecules are attached to the porous tip of a fused silica fiber (180 pm diameter) (16.17). The porous glass tip is coated with a thin gold layer, which insulates the sensor from interference by external light and is covered with an anticoagulant membrane that prevents clot formation upon contact with blood. Measurements of blood oxygen levels with this sensor are accurate and reliable (17). Calibration. Prior to each experiment, the sensor was calibrated for p02 measurements in the range of 28-57 mmHg by using distilled water equilibrated at 37°C with oxygen : nitrogen mixtures (4, 8 and 100% 02). At the end of each experiment, the oxygen sensor was placed in the calibration solution to ensure readout stability during the examination period.
In vivo oxygen measurements. The oxygen sensor was inserted a few millimeters into the desired tissue (kidney, spleen, striated muscle [Rectus abdominis or Psoas], subcutaneous tissues or tumor) of an anesthetized mouse, through a hypodermic needle (22 gauge). Oxygen levels were recorded under dark conditions until a stable p02 baseline was established. This baseline value was used as the normal tissue p02. In all experiments, the tumor was exposed to fractionated illumination for a few minutes prior to drug administration; this was done to assess the response of the sensor and the tumor to light. The Bchl-Ser was then injected directly into and allowed to spread in the tumor for 1-2 h. The site of injection was selected so as to be in proximity of the site of p02 measurement.
The tumor was then exposed to fractionated illumination for different time intervals. During the entire examination period, the PO, levels were continuously displayed on the computer screen as mmHg. Unless specified, measurements were carried out under normal atmospheric conditions. When indicated, a ventilation mask was used to provide the mice with 4% or 100% oxygen.
RESULTS

p02 in healthy and tumor tissues
In vivo PO, in solid tissues (kidney, spleen, striated muscle and subcutaneous tissue) of 15 mice and M2R tumors of 30 mice was measured with the oxygen sensor ( Table 1) . The recorded p02 levels in the healthy tissues were reproducible Photochemistry and Photobiology, 1997, 65(6) 1015 nw(mln) Figure 3 . Effect of light alone on the in vivo p 0 2 in an M2R melanoma tumor. The sensor was inserted into the tumor at t = 0, and at t = 95 and 105 rnin the tumor was illuminated for 5 min. The light intervals are indicated by the dashed areas.
and characteristic of the different organs. In contrast, PO, values for the tumors varied significantly, which suggested site dependence.
The dynamic response range of the oxygen sensor was demonstrated by monitoring the p 0 2 levels in two striated muscle sites: Rectus abdominis and Psoas. The p 0 2 levels in these sites were similar and around 39 mmHg (Fig. lA,  Table 1 ). Upon exposure of the mouse to 100% 0 2 ( t = 6: 40 min), the tissue p 0 2 increased almost instantaneously and reached -88 mmHg 2 min later. At this time the mouse was reexposed to normal atmosphere, which resulted in an initial rapid decrease of tissue p02, followed by a slow decline to a level lower than the initial baseline. This low reading seemed indicative of a respiration/perfusion failure. Despite reventilation with 100% oxygen for 2 min (starting at t = 34:40 min), which increased the PO, from -18 to 56 mmHg, the respiratiodperfusion failure was apparently irreversible and the animal died 15 min later. Concomitantly, the oxygen sensor showed a steady decline to zero. The cause of death was probably a combination of mechanical and oxygen toxicity apnea that often occurs in spontaneously breathing anesthetized or very young animals and also in human neonates (27, 28) .
Correlation between tissue PO, and the state of anesthesia of the mouse is exemplified in Fig. 1B . Under the skin of this anesthetized mouse, the baseline p 0 2 level was 32-40 mmHg during a period of 35 min. When a sudden increase in the p 0 2 level (t = 36 min), accompanied by movements of the anesthetized animal, was observed, a bolus of the anesthetics was administered. This slowly redeepened the level anesthesia, which caused a decline to baseline tissue pOz levels. When the mouse was transferred to a 4% 0, atmosphere for 1 min (t = 56 min), the tissue PO, immediately declined and reached a minimum of 3 1 mmHg. Subsequently, the PO, level overshot the baseline and stayed at 44 mmHg for the next 42 min. When the mouse was later exposed twice to 100% O2 , for only 1.5 and 2 min. a rapid but transient increase in the tissue p 0 2 occurred. Upon termination of the in vivo measurement, the sensor was removed, allowing spontaneous equilibration with room air (p02, 155 mmHg). These results demonstrated the ability of the sensor to determine p02 in normal solid tissues and demonstrated its dynamic behavior. 
Photodynamic damage induced in melanoma tumors by Bchl-Ser and light
The damage induced in solid M2R melanoma tumors treated by Bchl-Ser and light was determined histologically (Fig. 2) . Untreated tumor tissue ( Fig. 2A) consisted primarily of densely packed malignant cells (MC) with occasional melanotic areas (Mel) and well-defined blood vessels (BV) that were easily visualized when longitudinally displayed. Twenty four hours after exposure to Bchl-Ser and light, tissue destruction accompanied by significant vasodilation, hemorrhage (Hem) and necrosis (Nc) were observed in the treated tumors (Fig. 2B) . Administration of light alone or of Bchl-Ser with no subsequent illumination was without effect (data not shown).
PO, during fractionated illumination of tumors treated with Bchl-Ser
Following anesthesia of an M2R tumor-bearing mouse, the oxygen sensor was inserted into the tumor (t = 0 min) and the pOz levels were recorded until a stable baseline around 20 mmHg was established. Illumination of the tumor prior to drug administration had no effect on the p 0 2 level (Fig.  3) . This control was routinely performed before each experiment to ensure that the sensor is light impenetrable. The temporal response of tumor oxygen levels to Bchl-Ser and fractionated illumination was examined for a few hours in 30 M2R tumor-bearing mice. Various patterns of individual lighudark cycles (after Bchl-Ser administration) prompted respective oxygen depletion and repletion within seconds to minutes that appeared similar in all animals (Figs. 4-7) . Typical oxygen depletion and repletion profiles during the early lighudark cycles are depicted in Fig. 4A and B and were best fit by
for the period of illumination and by
for the period of oxygen recovery in the dark (with corre- lations of 0.994 and 0.993, respectively). The time (t) is given in seconds, k, and k,, the rate constants for oxygen depletion and repletion averaged from 10 different experiments are 0.03 2 5 X lo-) and 0.009 2 3 X mmHg s-l, respectively. A and B depend on the initial pOz level in each experiment. For the particular experiment depicted in Fig. 4 , the parameters A and B equal 0.8 and 15 mmHg, respectively. Usually it takes -100 s for complete depletion (where = 0 2 1 mmHg) and 360 s for the complete repletion of the oxygen content in the tumor tissue (Fig. 
4).
To calculate the corresponding average rates of light-dependent oxygen consumption and tumor reoxygenation (in the dark), K, and KO, respectively, we have made the following assumptions: (a) the blood flow rate is 0.025 mL/(min cmz) (29,30); (b) the photodynamic action of Bchl-Ser consumes both the soluble and hemoglobin-bound oxygen fractions; (c) during the dark period the bound and soluble oxygen are recovered to their preillumination levels; (d) hypoxia imposed by the photodynamic process increases the arteriovenous oxygen extraction from 5 to 15% (vol/vol) of the total blood supply (15).
During the 6 min dark period (Fig. 4B) Comparison of these values with those given in the literature for oxygen consumption due to photofrin-based PDT has to consider the different pigment concentrations in the tumor tissue and the actual light absorbed by the sensitizer at the applied light domains (10). An accurate number cannot be provided at the moment because we did not measure the pigment concentration within the tumor at the time of irradiation. However, starting with 200 kg of Bchl-Ser/S g tumor tissue and assuming half-life time of 2.5 h for the The long-term response that developed within a few hours of illumination displayed three different patterns of behavior. This phenomenon was further examined in 12 of the tumorbearing animals studied. The first pattern, showing an eventual loss of the oxygen depletion effect (Fig. 5 ) was observed in four animals. The sensor was inserted into the tumor at t = 0 min. The Bchl-Ser was administered at t = 106 min, and 2 h later (t = 226 min) the tumor was illuminated for the first time. This first illumination of the tumor, even if for only 20 s, which was in the presence of Bchl-Ser, induced a prompt depletion of the tumor oxygen levels to 5-8 mmHg. During the ensuing dark period, the pOz was completely replenished to preillumination baseline levels (-30 mmHg). This was followed by the administration of various illumination periods and intervals between illuminations as indicated. During the first few light/dark cycles (226 < t < 275 min), oxygen levels dropped to nearly zero upon illumination, which indicated a high efficiency of oxygen consumption. However, upon additional exposures, the oxygen depletion due to exposure to light became progressively smaller. At t > 275 min, the postillumination oxygen levels overshot the baseline values and progressively increased. A correlation between oxygen depletion and illumination was observed only in the presence of Bchl-Ser, which suggests that interaction of the drug and light was necessary for attenuation of the tumor p02.
In a second pattern of behavior (Fig. 6) , followed in four mice, we observed temporal variations in the tumor oxygen levels although the oxygen depletiodrepletion effect was kept throughout the entire irradiation time. The tumor, injected with Bchl-Ser was exposed to light/dark cycles of -5 TIME (mln) Figure 7 . The long-term in vivo PO, in M2R mouse melanoma under PDT conditions (pattern 3). Sensor inserted at t = 0, BchlSer administrated at t = 15 min and fractionated illumination -5 rnin light/-5 min dark started at t = 95 min. The light intervals are indicated by the dashed areas. min each. The PO, baseline in the dark periods increased steadily (146 < t < 300 min), then appeared to stabilize for several hours, and later displayed a slight decline (300 < t < 490 min). With this protocol of exposure to light (alternating periods of -5 min light and dark), a third pattern (Fig. 7) was also observed in four mice. Here, an eventual depletion of the entire oxygen content was observed. During the early dark intervals (95 < t < 160 min), the tumor p02 levels consistently returned to the preirradiation baseline levels. However, with increasing time (160 < t < 270 min), the pOz baseline during the dark intervals progressively declined, and as it approached zero, there was an attenuation of the response to light. Complete depletion of oxygen, as a result of illumination (Figs. 6 and 7) , indicated that the BchlSer concentration was in excess throughout the experiment.
The depth to which the light penetrates into the tumor was estimated by controlled insertion of the sensor into the tumor. Light-dependent oxygen consumption could be observed by insertion of the sensor up to a depth of -8-9 mm from the skin.
DISCUSSION
This study examined the spatial and temporal variations in the concentration of oxygen within solid tumors, especially the rate of oxygen depletion and repletion during PDT. While homeostatic p02 values were previously measured by polarographic techniques, reports on direct measurement of temporal oxygen variations in situ and with sufficient hightime resolution were lacking. Application of a newly developed optical sensor enabled the execution of such in vivo measurements at a time resolution of <1 s, comparison of the recorded data with theoretical considerations and the proposal of a light regimen for effective PDT.
Our continuous measurements in situ of the homeostatic oxygen pressure in normal and tumor tissues (Table 1) are in good agreement with previous polarographic measurements (31-38). The observed variations in pOz within a particular tumor and between tumors of different animals not subjected to PDT (Table 1 ) are probably due to the heterogenous morphology of these solid tumors. This heterogeneity of tumor p02 was previously attributed to variations in vascular density and uneven distribution of regions containing proliferating, quiescent andor necrotic zones (24, 26, 30) .
The rapid and total depletion of local oxygen upon illumination of tumors that contained saturating concentrations of sensitizers was previously predicted (10,ll). In fact, following application of Bchl-Ser and subsequent illumination, the measured tumor p02 values dropped rapidly, often to below instrumental resolution (Figs. 5-7 ). and returned to baseline level only after the light was turned off. Exposure to light alone or application of Bchl-Ser alone did not affect the pOz in solid M2R tumors. The in vivo light-dependent oxygen consumption as mediated by Bchl-Ser suggests its potential to deliver PDTII in a manner similar to chlorophyll-serine which has been demonstrated by us to generate Although the short-term p 0 2 response to illumination after administration of Bchl-Ser was similar in all the animals tested (Figs. 4-7) , the long-term response could follow one of at least three patterns of behavior that are probably related to development of vascular damage as exemplified in Fig.  2B . In this experiment, spillage of blood into the damaged area and hemorrhage formation due to vascular injury may culminate in clot formation and blood stasis with consequent impact on local p02 distribution (4.40). In one pattern, a progressive decline in the effect of light on PO, and a slight increase in the baseline oxygen levels in the dark occurs (Fig. 5) . A simple mathematical manipulation shows that both the amount and rate of oxygen depletion are proportional to the sensitizer concentration in the treated zone (Eqs. A2 and A3 in Foster et al. (10)). Thus, a decrease in the extent of oxygen depletion observed in this pattern should reflect a decrease in the concentration of Bchl-Ser within the irradiated zone. This phenomenon could be explained by. pigment degradation and photobleaching within the irradiated zone, as well as by fast tissue and vascular clearance due to the high water solubility of Bchl-Ser. If the latter is indeed correct, then the clearance rate for Bchl-Ser from the tumor under illumination (t,,* = 2.5 h) would be significantly higher than that reported earlier by us for M2R tumors in unilluminated mice (21). Both the fast clearance of Bchl-Ser and the increase in oxygen concentrations during dark periods might be related to local vascular damage. The slow, but steady, increase in the p 0 2 baseline during dark periods (Fig. 5 ) may be indicative of decreased metabolism, which accompanies photodynamic cell destruction. Furthermore, the spillage of blood into the damaged area may temporally elevate p02 to levels existing in adjacent blood vessels (Fig.  2B) . At times relatively late after illumination of the BchlSer-treated tumor region, moderate oxygen repletion started even during the light period (Fig. 5, t > 270 min) . In this case, the local concentration of Bchl-Ser probably became the rate-limiting factor for light-dependent oxygen consumption, but due to some pigment redistribution into the site of measurement the process did not totally stop. Indeed when illumination was terminated, the rate of oxygen repletion was immediately enhanced due to elimination of the competition for oxygen by the residual photodynamic process. Further diffusion of residual Bchl-Ser into the examined site enabled brief depletion spikes in response to light at each lighvdark cycle. The magnitude of these spikes became progressively smaller, apparently reflecting the trend of BchlSer clearance.
The other two patterns of long-term behavior of tissue p02 during fractionated illumination of Bchl-Ser-treated tumors (Figs. 6 and 7) probably reflect on the vascular density within or near the examined zone. In both, complete oxygen depletion during illumination is observed throughout the entire experiment. However, while one is characterized by complete oxygen recovery in the dark to a relatively constant baseline (Fig. 6) . in the other there is a progressive decline of baseline PO, in the dark that approaches zero (Fig. 7) . For complete oxygen recovery to occur, the inspected zone must be within 160 pm of active capillaries (10,ll). Such a situation is probable in a tumor site that is rich in vasculature. In that case, a low fluence rate of illumination, such as that used in the present study, will insult only part of the capillary bed and continuous oxygen supply will be ensured by the remaining undamaged part. In contrast, if the monitored zone is positioned at a tumor site with poor vasculature, damage to the capillaries may result in complete discontinuation of the oxygen supply.
Similar long-term patterns were reported previously using the transcutaneous Clark electrodes (15). However, the short-term pattern observed here allows relation of these patterns with the tumor microenvironment in real time. Yet, the suggested explanations for these patterns are awaiting verification by complementary methodologies, such as magnetic resonance imaging.
In conclusion, under conditions where the oxygen concentration is the rate-limiting factor of PDTII, optimal oxygen consumption can probably be achieved by fractionated illumination at a moderate fluence rate, where the light delivery is synchronized with the oxygen recovery. Our data support the hypothesis that an alternate lighvdark cycle provides optimum oxygen consumption that eventually may lead to optimal PDT effect (10,ll). However, the light and dark durations depend upon the concentration and absorbance of the photosensitizer as well as upon the light fluence rate.
